Clinical trial
Multimodal Al for Precision Diagnosis of Esophageal Cancer
NCT07629921 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multimodal Al for Precision Diagnosis of Esophageal Cancer
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 1, 2023
- Completion date
- June 7, 2026
- Enrollment
- 264 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer